Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 25

1.

A novel haplotype of low-frequency variants in the aldosterone synthase gene among northern Han Chinese with essential hypertension.

Zhang H, Li X, Zhou L, Zhang K, Zhang Q, Li J, Wang N, Jin M, Wu N, Cong M, Qiu C.

Medicine (Baltimore). 2017 Sep;96(39):e8150. doi: 10.1097/MD.0000000000008150.

2.

Immunohistochemistry of aldosterone synthase leads the way to the pathogenesis of primary aldosteronism.

Nishimoto K, Koga M, Seki T, Oki K, Gomez-Sanchez EP, Gomez-Sanchez CE, Naruse M, Sakaguchi T, Morita S, Kosaka T, Oya M, Ogishima T, Yasuda M, Suematsu M, Kabe Y, Omura M, Nishikawa T, Mukai K.

Mol Cell Endocrinol. 2017 Feb 5;441:124-133. doi: 10.1016/j.mce.2016.10.014. Epub 2016 Oct 14. Review.

3.

Adrenal Mitochondria and Steroidogenesis: From Individual Proteins to Functional Protein Assemblies.

Midzak A, Papadopoulos V.

Front Endocrinol (Lausanne). 2016 Jul 29;7:106. doi: 10.3389/fendo.2016.00106. eCollection 2016. Review.

4.

Corticosterone Methyl Oxidase Deficiency Type 1 with Normokalemia in an Infant.

Üstyol A, Atabek ME, Taylor N, Yeung MC, Chan AO.

J Clin Res Pediatr Endocrinol. 2016 Sep 1;8(3):356-9. doi: 10.4274/jcrpe.2824. Epub 2016 Apr 29.

5.

Antiaging Gene Klotho Regulates Adrenal CYP11B2 Expression and Aldosterone Synthesis.

Zhou X, Chen K, Wang Y, Schuman M, Lei H, Sun Z.

J Am Soc Nephrol. 2016 Jun;27(6):1765-76. doi: 10.1681/ASN.2015010093. Epub 2015 Oct 15.

6.

A recombinant CYP11B1 dependent Escherichia coli biocatalyst for selective cortisol production and optimization towards a preparative scale.

Schiffer L, Anderko S, Hobler A, Hannemann F, Kagawa N, Bernhardt R.

Microb Cell Fact. 2015 Feb 25;14:25. doi: 10.1186/s12934-015-0209-5.

7.

Adrenal CYP11B1/2 expression in primary aldosteronism: immunohistochemical analysis using novel monoclonal antibodies.

Nakamura Y, Maekawa T, Felizola SJ, Satoh F, Qi X, Velarde-Miranda C, Plonczynski MW, Ise K, Kikuchi K, Rainey WE, Gomez-Sanchez EP, Gomez-Sanchez CE, Sasano H.

Mol Cell Endocrinol. 2014 Jul 5;392(1-2):73-9. doi: 10.1016/j.mce.2014.05.002. Epub 2014 May 14.

8.

Development of monoclonal antibodies against human CYP11B1 and CYP11B2.

Gomez-Sanchez CE, Qi X, Velarde-Miranda C, Plonczynski MW, Parker CR, Rainey W, Satoh F, Maekawa T, Nakamura Y, Sasano H, Gomez-Sanchez EP.

Mol Cell Endocrinol. 2014 Mar 5;383(1-2):111-7. doi: 10.1016/j.mce.2013.11.022. Epub 2013 Dec 8.

9.

Structural insights into aldosterone synthase substrate specificity and targeted inhibition.

Strushkevich N, Gilep AA, Shen L, Arrowsmith CH, Edwards AM, Usanov SA, Park HW.

Mol Endocrinol. 2013 Feb;27(2):315-24. doi: 10.1210/me.2012-1287. Epub 2013 Jan 15.

10.

Alteration in accumulated aldosterone synthesis as a result of N-terminal cleavage of aldosterone synthase.

Adams BP, Bose HS.

Mol Pharmacol. 2012 Mar;81(3):465-74. doi: 10.1124/mol.111.076471. Epub 2011 Dec 19.

11.

Adrenocortical causes of hypertension.

Moraitis A, Stratakis C.

Int J Hypertens. 2011 Mar 8;2011:624691. doi: 10.4061/2011/624691.

12.

Identification of SPRED2 (sprouty-related protein with EVH1 domain 2) as a negative regulator of the hypothalamic-pituitary-adrenal axis.

Ullrich M, Bundschu K, Benz PM, Abesser M, Freudinger R, Fischer T, Ullrich J, Renné T, Walter U, Schuh K.

J Biol Chem. 2011 Mar 18;286(11):9477-88. doi: 10.1074/jbc.M110.171306. Epub 2011 Jan 3.

13.

RAAS and adrenergic genes in heart failure: Function, predisposition and survival implications.

Alves AJ, Eynon N, Oliveira J, Goldhammer E.

World J Cardiol. 2010 Jul 26;2(7):187-97. doi: 10.4330/wjc.v2.i7.187.

14.

The molecular biology, biochemistry, and physiology of human steroidogenesis and its disorders.

Miller WL, Auchus RJ.

Endocr Rev. 2011 Feb;32(1):81-151. doi: 10.1210/er.2010-0013. Epub 2010 Nov 4. Review. Erratum in: Endocr Rev. 2011 Aug;32(4):579.

15.

Regulation of adrenal aldosterone production by serine protease prostasin.

Ko T, Kakizoe Y, Wakida N, Hayata M, Uchimura K, Shiraishi N, Miyoshi T, Adachi M, Aritomi S, Konda T, Tomita K, Kitamura K.

J Biomed Biotechnol. 2010;2010:793843. doi: 10.1155/2010/793843. Epub 2010 Mar 2.

16.

Regulation of aldosterone and cortisol production by the transcriptional repressor neuron restrictive silencer factor.

Somekawa S, Imagawa K, Naya N, Takemoto Y, Onoue K, Okayama S, Takeda Y, Kawata H, Horii M, Nakajima T, Uemura S, Mochizuki N, Saito Y.

Endocrinology. 2009 Jul;150(7):3110-7. doi: 10.1210/en.2008-1624. Epub 2009 Apr 2.

17.

Analysis of renin-angiotensin aldosterone system gene polymorphisms in Malaysian essential hypertensive and type 2 diabetic subjects.

Ramachandran V, Ismail P, Stanslas J, Shamsudin N.

Cardiovasc Diabetol. 2009 Feb 25;8:11. doi: 10.1186/1475-2840-8-11.

18.

A novel genetic locus for low renin hypertension: familial hyperaldosteronism type II maps to chromosome 7 (7p22).

Lafferty AR, Torpy DJ, Stowasser M, Taymans SE, Lin JP, Huggard P, Gordon RD, Stratakis CA.

J Med Genet. 2000 Nov;37(11):831-5.

19.

Mutations in the CYP11B1 gene causing congenital adrenal hyperplasia and hypertension cluster in exons 6, 7, and 8.

Curnow KM, Slutsker L, Vitek J, Cole T, Speiser PW, New MI, White PC, Pascoe L.

Proc Natl Acad Sci U S A. 1993 May 15;90(10):4552-6.

20.

Glucocorticoid-suppressible hyperaldosteronism and adrenal tumors occurring in a single French pedigree.

Pascoe L, Jeunemaitre X, Lebrethon MC, Curnow KM, Gomez-Sanchez CE, Gasc JM, Saez JM, Corvol P.

J Clin Invest. 1995 Nov;96(5):2236-46.

Supplemental Content

Support Center